Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - RESEARCH & DEVELOPMENT
Research & Development HALO - Halozyme Therapeutics, Inc.
79 M
LAST VALUE
8.94%
2 YEAR CAGR
-10.90%
5 YEAR CAGR
-0.08%
10 YEAR CAGR